Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Preferred Shares (2016 - 2021)

Cardiff Oncology (CRDF) has disclosed Preferred Shares for 11 consecutive years, with $1000.0 as the latest value for Q4 2021.

  • Quarterly Preferred Shares changed 0.0% to $1000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Dec 2021, changed 0.0% year-over-year, with the annual reading at $1000.0 for FY2021, 0.0% changed from the prior year.
  • Preferred Shares hit $1000.0 in Q4 2021 for Cardiff Oncology, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $1000.0 in Q4 2020 to a low of $60.0 in Q1 2017.
  • Historically, Preferred Shares has averaged $391.9 across 5 years, with a median of $60.0 in 2017.
  • Biggest YoY gain for Preferred Shares was 1566.67% in 2020; the steepest drop was 76.92% in 2020.
  • Year by year, Preferred Shares stood at $60.0 in 2017, then changed by 0.0% to $60.0 in 2018, then changed by 0.0% to $60.0 in 2019, then surged by 1566.67% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
  • Business Quant data shows Preferred Shares for CRDF at $1000.0 in Q4 2021, $1000.0 in Q3 2021, and $1000.0 in Q2 2021.